Checkpoint Capital L.P. Quant / Systematic

Location: San Francisco, CA

CIK: 0001977548 · Show all filings

Period: Q4 2023 (Next →)

Filing Date: Feb 14, 2024

Total Value: $165M (100.0% shares, 0.0% debt)

Holdings (19)

RYTM RHYTHM PHARMACEUTICALS INC 20.3%
Value $33.56M Shares 730,000 Est. Cost $31.55 Unrealized 0.0%
ARGX ARGENX SE 16.1%
Value $26.63M Shares 70,000 Est. Cost $380.43 Unrealized
CYTK CYTOKINETICS INC 11.6%
Value $19.2M Shares 230,000 Est. Cost $36.21 Unrealized 0.0%
XBI SPDR BIOTECH ETF TR 9.7%
Value $16.07M Shares 180,000 Est. Cost Unrealized
SPRINGWORKS THERAPEUTICS INC 7.5%
Value $12.41M Shares 340,000 Est. Cost $36.50 Unrealized
AXSM AXSOME THERAPEUTICS INC 7.5%
Value $12.36M Shares 155,346 Est. Cost $66.86 Unrealized 0.0%
IRWD IRONWOOD PHARMACEUTICALS INC 6.1%
Value $10.07M Shares 880,000 Est. Cost $9.89 Unrealized 0.0%
MIRM MIRUM PHARMACEUTICALS INC 4.2%
Value $6.898M Shares 233,659 Est. Cost $30.26 Unrealized 0.0%
PTGX PROTAGONIST THERAPEUTICS INC 3.7%
Value $6.119M Shares 266,856 Est. Cost $17.50 Unrealized 0.0%
IRWD IRONWOOD PHARMACEUTICALS INC 3.5%
Value $5.72M Shares 500,000 Est. Cost $9.89 Unrealized 0.0%
AVADEL PHARMACEUTICALS PLC 2.8%
Value $4.589M Shares 325,000 Est. Cost $14.12 Unrealized
PHAT PHATHOM PHARMACEUTICALS INC 2.0%
Value $3.282M Shares 359,446 Est. Cost $8.62 Unrealized 0.0%
ATYR ATYR PHARMA INC 1.3%
Value $2.12M Shares 1,503,554 Est. Cost $1.28 Unrealized 0.0%
TRVI TREVI THERAPEUTICS INC 1.0%
Value $1.732M Shares 1,292,316 Est. Cost $1.51 Unrealized 0.0%
GHRS GH RESEARCH PLC 1.0%
Value $1.705M Shares 293,945 Est. Cost $7.06 Unrealized 0.0%
ALLAKOS INC 0.7%
Value $1.214M Shares 444,804 Est. Cost $2.73 Unrealized
IRON DISC MEDICINE INC 0.3%
Value $578K Shares 10,000 Est. Cost $51.20 Unrealized 0.0%
ACRS ACLARIS THERAPEUTICS INC 0.3%
Value $476K Shares 453,614 Est. Cost $3.05 Unrealized 0.0%
EWTX EDGEWISE THERAPEUTICS INC 0.2%
Value $361K Shares 33,000 Est. Cost $7.02 Unrealized 0.0%